Molecular markers in ductal carcinoma in situ of the breast.
Gene expression patterns in ductal carcinoma in situ (DCIS), and in invasive, and metastatic breast tumors were determined using serial analysis of gene expression (SAGE). We used mRNA in situ hybridization to examine gene expression at the cellular level and immunohistochemistry on tissue microarrays to determine association between gene expression patterns and histopathologic characteristics of the tumors. We found that that the most dramatic transcriptome change occurs at the normal to DCIS transition, while there is no clear universal "in situ" or "invasive" tumor molecular signature. From the 16,430 transcripts analyzed, we identified only 5 and 11 that were preferentially up-regulated in DCIS and invasive tumors, respectively. The majority of invasive cancer specific SAGE tags correspond to novel genes. The genes we identified may define biologically and clinically meaningful subgroups of DCIS with a high risk of progression to invasive disease.
Porter
Dale
D
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Lahti-Domenici
Jaana
J
Keshaviah
Aparna
A
Bae
Young Kyung
YK
Argani
Pedram
P
Marks
Jeffrey
J
Richardson
Andrea
A
Cooper
Amiel
A
Strausberg
Robert
R
Riggins
Gregory J
GJ
Schnitt
Stuart
S
Gabrielson
Edward
E
Gelman
Rebecca
R
Polyak
Kornelia
K
D001943:Breast Neoplasms / Q000235:genetics*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000235:genetics*; D015536:Down-Regulation / Q000235:genetics; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D015723:Gene Library; D005819:Genetic Markers; D006801:Humans; D007150:Immunohistochemistry; D020411:Oligonucleotide Array Sequence Analysis; D015854:Up-Regulation / Q000235:genetics
D005819:Genetic Markers